Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer.
CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer. Am J Surg. 1996 Oct; 172(4):350-2.
View in:
PubMed
subject areas
Adult
Aged
CA-19-9 Antigen
Combined Modality Therapy
Female
Fluorouracil
Humans
Laparotomy
Male
Middle Aged
Pancreatic Neoplasms
Peritoneal Neoplasms
Radiotherapy Dosage
Treatment Outcome
authors with profiles
Andrew Louis Warshaw, M.D.